1. Home
  2. ABG vs ACAD Comparison

ABG vs ACAD Comparison

Compare ABG & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asbury Automotive Group Inc

ABG

Asbury Automotive Group Inc

HOLD

Current Price

$189.02

Market Cap

4.5B

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$20.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABG
ACAD
Founded
1996
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.9B
IPO Year
2001
2000

Fundamental Metrics

Financial Performance
Metric
ABG
ACAD
Price
$189.02
$20.66
Analyst Decision
Hold
Buy
Analyst Count
6
22
Target Price
$251.33
$30.45
AVG Volume (30 Days)
191.0K
1.8M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
16.88
69.12
EPS
25.13
2.30
Revenue
$17,999,000,000.00
$726,437,000.00
Revenue This Year
$6.03
$18.52
Revenue Next Year
$2.48
$11.34
P/E Ratio
$7.54
$8.82
Revenue Growth
4.71
40.45
52 Week Low
$186.27
$14.08
52 Week High
$274.50
$28.35

Technical Indicators

Market Signals
Indicator
ABG
ACAD
Relative Strength Index (RSI) 22.40 36.97
Support Level N/A $20.45
Resistance Level $255.30 $22.75
Average True Range (ATR) 6.50 0.90
MACD -1.14 -0.15
Stochastic Oscillator 15.04 18.76

Price Performance

Historical Comparison
ABG
ACAD

About ABG Asbury Automotive Group Inc

Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 152 new-vehicle stores and 37 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 14 states (mostly Texas, the West, the Mid-Atlantic, and the Southeast). Asbury store brands include McDavid and Park Place in Texas, Koons in the Washington, D.C. area, and the Larry H. Miller brand in the Western US. Asbury generated $17.2 billion of revenue in 2024 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: